Medical Properties Trust

Shares of Medical Properties Trust hit a 52-week low of $3.89, down about 17% year to date and nearly 25% over the past six months. The stock trades roughly 40% below its 52-week high and currently yields about 9% in dividends, with dividends paid for 22 years. In Q2 2026, Medical Properties Trust beat revenue expectations with $259.28 million but reported a small loss of $0.01 per share; normalized FFO remained stable at $0.15. To manage maturities, the company completed a private placement of $2.4 billion of senior secured notes (9.25%, due 2032) to refinance existing liabilities. » More on de.investing.com

Shares of Medical Properties Trust fell to a 52-week low of $3.96, leaving them down 11.78% year to date. In Q2 2026 revenue of $259.28 million beat expectations, but showed a small loss of $0.01 per share; normalized FFO remained stable at $0.15. The company plans the issuance of $2.4 billion of senior secured notes to refinance maturing debt; the stock offers a dividend yield of 8.8% and is rated below fair value by InvestingPro. » More on de.investing.com

Shares of Medical Properties Trust hit a new 52-week low of $3.99 and remain under sustained pressure; they are down 15.9% year-to-date and 21.7% over six months. The company completed a private placement and an exchange transaction that issued $2.4 billion of senior secured notes (maturing 2032) and refinanced about $1.5 billion of unsecured notes with maturities from 2027–2031. In the second quarter, revenue of $259.28 million beat expectations but showed a small loss of $0.01 per share; normalized FFO were $0.15 per share. Management reports progress on its refinancing plan to eliminate debt maturities through 2027; market capitalization is $2.39 billion with a dividend yield of 8.89%, and analysts see a possible return to profitability. » More on de.investing.com